$Cris my idea on curis stock potential hitting 12 $ afeter breaking out of that bullish triangle flag
Key stats
Market capitalization
53.121MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.6089USD
About Curis, Inc
ISIN
US2312692005
Sector
Health Technology
Industry
Biotechnology
Website
curis.com
CEO
James E. Dentzer
Headquarters
Lexington
Employees
51
Founded
2000
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0